Iovance Biotherapeutics Inc (NAS:IOVA)
$ 7.78 -0.36 (-4.42%) Market Cap: 2.18 Bil Enterprise Value: 2.01 Bil PE Ratio: 0 PB Ratio: 3.20 GF Score: 35/100

Iovance Biotherapeutics Inc at Jefferies Virtual London Healthcare Conference Transcript

Nov 19, 2020 / 05:35PM GMT
Release Date Price: $36.59 (+0.25%)
Dingding Shi
Jefferies LLC, Research Division - Equity Analyst

Good afternoon, everyone. My name is Kelly Shi, one of the biotech research analysts at Jefferies. Thank you, everyone online, for attending our Virtual London Healthcare Conference. Today, we are very pleased that we have Ms. Maria Fardis, the Chief Executive Officer of Iovance Biotherapeutics, joining us for this fireside chat session. And at the end of the session, if time allows, we will have a Q&A. (Operator Instructions)

And thank you for joining us, Maria.

Questions & Answers

Dingding Shi
Jefferies LLC, Research Division - Equity Analyst

Before we get into some of the more detailed questions, maybe we can touch on the high level and then your vision or your (inaudible) for TIL therapies. You've made significant strides since becoming CEO. Do you see TILs as a therapy for earlier lines? Or do you expect these therapies will be relegated to last in line?

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot